The Women's March endorsed progressive House candidate Nina Turner on Tuesday ahead of the Democratic primary in Ohio's 11th Congressional District, marking the group's first-ever electoral endorsement.

The Hill was the first outlet to report on the endorsement, which was released through the group's new super PAC, Women’s March Win.

Last summer, a team at the Boston Fed started to work with researchers at the Massachusetts Institute of Technology to find out what it would take to build a U.S.-backed digital currency.

A Fed-backed digital dollar wouldn’t be a cryptocurrency based on decentralized blockchain, the ledger-based technology that underpins traditional digital currencies like bitcoin BTCUSD . It would merely be a digitized form of the fiat dollars that the Fed issues, and with which Americans are the most familiar, essentially antithetical to assets like bitcoin, in the eyes of cryptocurrency purists.

Dogecoin continues its scarcely believable surge.
By Jason Karaian
May 5, 2021, 8:25 a.m. ET
Dogecoin, the cryptocurrency that started as a joke, is on a tear. A surge in the past day pushed it to another record, sending it some 14,000 percent higher than it started the year.

One theory is that the upcoming appearance of Elon Musk, the Tesla chief executive and noted Dogecoin superfan, as the host of “Saturday Night Live” on May 8 could get more people interested in trading the crypto token. It’s as good a reason as any for those who try to rationalize its movements.

The latest bout of Dogecoin mania has somewhat overshadowed what’s going on in Ethereum, the second-largest cryptocurrency, which also set records this week and made its 27-year-old co-creator, Vitalik Buterin, a billionaire (in dollars). The price of Ether, the crypto token built on the Ethereum blockchain, is up more than 350 percent for the year to date, outpacing Bitcoin’s relatively pedestrian 90 percent gain — which, for context, outpaces every stock in the S&P 500 over that period.

Israel has delivered just under 10 million doses of the two-shot Pfizer vaccine regimen, reaching 4.98 million people, or about 55 percent of its total population. An additional 400,000 Israelis have received one shot. If those who have been infected and then recovered are added in, more than 60 percent of Israeli residents now have some level of protective antibodies. The virus is running short of vulnerable bodies to infect.